EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center

Hayet Kaaroud, Amel Harzallah iD, Mariem Hajji, Soumaya Chargui, Samia Barbouch, Sami Turki, Raja Trabelsi, Rim Goucha, Fatma Ben Moussa, Hedi Ben Maiz, Fethi Ben Hamida, Ezzeddine Abderrahim

International Journal of Nephrology · 18.07.2022 · 2022 · 1-9

DOI: 10.1155/2022/8493479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nephrology, erschienen am 18.07.2022. Verfasst von Hayet Kaaroud und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine A, Charles Nicolle Hospital, Tunis, Tunisia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Renal amyloidosis is one of the main differential diagnoses of nephrotic proteinuria in adults and the elderly. The aim of this study with the most important series in our country is to contribute to the epidemiological, clinical, and etiological study of the renal amyloidosis.

Methods

In a retrospective study carried out between 1975 and 2019, 310 cases of histologically proven and typed renal amyloidosis were selected for this study.

Results

There were 209 men and 101 women with a mean age of 53.8 ± 15.4 years (range, 17–84 years). Of the 310 cases, 255 (82.3%) were diagnosed with AA renal amyloidosis and 55 (17.7%) with non-AA amyloidosis. Infections were the main cause of AA amyloidosis, and tuberculosis was the most frequent etiology. The period from the onset of the underlying disease to diagnosis of the renal amyloidosis was an average of 177 months. The most frequent manifestations at the time of diagnosis were nephrotic syndrome (84%), chronic renal failure (30.3%), and end-stage renal disease (37.8%). After a medium follow-up of 16 months (range, 0–68 months), mortality occurred in 60 cases.

Conclusions

Given the high frequency of AA amyloidosis in our country, awareness of the proper management of infectious and chronic inflammatory diseases remains a priority in reducing the occurrence of this serious disease.

Autor:innen und Institutionen

  • Department of Medicine A, Charles Nicolle Hospital, Tunis, Tunisia.
  • Laboratory of Renal Pathology LR00SP01, Charles Nicolle Hospital, Tunis, Tunisia.
  • Faculty of Medicine of Tunis, University of Tunis, El Manar, Tunis, Tunisia.

ORCID-Profile: Amel Harzallah

Zitieren

APA

Kaaroud, H., Harzallah, A., Hajji, M., Chargui, S., Barbouch, S., Turki, S., Trabelsi, R., Goucha, R., Ben Moussa, F., Ben Maiz, H., Ben Hamida, F., & Abderrahim, E. (2022). Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center. International Journal of Nephrology, 2022, 1-9. https://doi.org/10.1155/2022/8493479

Vancouver

Kaaroud H, Harzallah A, Hajji M, Chargui S, Barbouch S, Turki S, et al. Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center. International Journal of Nephrology. 2022;2022:1-9. doi:10.1155/2022/8493479

BibTeX
@article{Kaaroud2022,
  author = {Kaaroud, Hayet and Harzallah, Amel and Hajji, Mariem and Chargui, Soumaya and Barbouch, Samia and Turki, Sami and Trabelsi, Raja and Goucha, Rim and Ben Moussa, Fatma and Ben Maiz, Hedi and Ben Hamida, Fethi and Abderrahim, Ezzeddine},
  title = {Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center},
  journal = {International Journal of Nephrology},
  year = {2022},
  volume = {2022},
  pages = {1--9},
  doi = {10.1155/2022/8493479}
}
Kostenlos starten →